Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levofloxacin 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 5mg/mL infusion solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 25mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 25mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 25mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 5mg/ml ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing levofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing levofloxacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 5mg/mL intravenous injection solution 150mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 5mg/mL intravenous injection solution 100mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 5mg/mL intravenous injection solution 50mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 1.5% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 25mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing levofloxacin in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Allergy to levofloxacin |
Causative agent (attribute) |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
2 |
Levofloxacin hemihydrate (substance) |
Is a |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Levofloxacin 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 750 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 750 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin hemihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 500 milligram/100 milliliter conventional release solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing levofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Allergy to levofloxacin |
Causative agent (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only levofloxacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only levofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Levofloxacin 5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Dexamethasone- and levofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing only dexamethasone and levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
2 |
Dexamethasone- and levofloxacin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing only dexamethasone and levofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levofloxacin (substance) |
Inferred relationship |
Some |
1 |